MedWatch Technologies

MedWatch Technologies develops a non-invasive wearable health management platform combining breakthrough biosensing technology with AI coaching to deliver proactive metabolic health monitoring. The platform offers a wearable watch and tools that enable users to continuously monitor glucose metrics and adjust their diet and lifestyle in response to real-time data, providing a comprehensive approach to metabolic health management without invasive blood sampling. The system integrates continuous glucose monitoring with AI-driven coaching that interprets biosensor data and delivers personalized health recommendations. Founded in 2022 and headquartered in the United States, the company has raised approximately $17.6M in Series A funding. MedWatch Technologies differentiates itself through its non-invasive approach to glucose monitoring, combining biosensing hardware with AI coaching software to create a proactive health management experience that goes beyond passive monitoring to deliver actionable lifestyle and dietary guidance based on immediate metabolic metrics.